Feb 2020

Indication Focused RBQM for Rare Disease Drug Development

By |2020-02-28T08:30:17+00:00February 28, 2020|Blog|0 Comments

Adaptive and intelligent Risk Based Quality Management (RBQM) is a powerful strategy for rare disease research. One of the main benefits is that RBQM allows for patient-centric trial design that is uniquely tailored to the specific rare disease.

Upcoming Events

  1. CORE West by Halloran

    September 22 - September 24
  2. 25. Jahrestagung der GQMA

    September 23 - September 24

Register Today!

Get Free Test Access
Go to Top